Crossmark

Real life experience of molnupiravir as a treatment of SARS-CoV-2 infection in vaccinated and unvaccinated patients: a letter on its effectiveness at preventing hospitalization

Crossref DOI link: https://doi.org/10.1007/s11845-022-03241-1

Published Online: 2022-12-01

Published Print: 2023-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Scioscia, Giulia

De Pace, Cosimo Carlo

Giganti, Giulio

Tondo, Pasquale

Foschino Barbaro, Maria Pia

Lacedonia, Donato
License Information

Text and Data Mining valid from 2022-12-01

Version of Record valid from 2022-12-01
More Information

Article History

Received: 21 November 2022

Accepted: 24 November 2022

First Online: 1 December 2022

Declarations

:

: The authors declare no competing interests.

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below